JV-GL1

· JeniVision, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for JV-GL1, covering 2024-05-10 to 2024-05-10. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Efficacy Study of JV-GL1 in Patients With Open-Angle Glaucoma or Ocular Hypertension [Phase 1, Phase 2]

See pricing